# Arbutus Biopharma Corp: Form 8-K, filed Feb 28, 2022

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2022-02-28
- Accepted by EDGAR: Feb 28, 2022, 06:15 ET
- Period: 2022-02-28
- Accession: 0001171843-22-001419
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184322001419/f8k_022822.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184322001419/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184322001419/f8k_022822.htm

Filed Feb 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-001419. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.